ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

VTVT vTv Therapeutics Inc

23.63
-0.0699 (-0.29%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
vTv Therapeutics Inc VTVT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0699 -0.29% 23.63 14:00:09
Open Price Low Price High Price Close Price Previous Close
22.85 22.5001 24.33 23.63 23.6999
more quote information »

Recent News

Date Time Source Heading
19/3/202423:30PRNUSCANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA..
13/3/202423:00GLOBEvTv Therapeutics Announces 2023 Fourth Quarter and Full Year..
08/3/202408:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/3/202411:52EDGAR2Form SC 13D - General statement of acquisition of beneficial..
06/3/202400:04EDGAR2Form 8-K - Current report
05/3/202400:00GLOBEvTv Therapeutics Announces FDA Submission for First Phase 3..
02/3/202400:00GLOBEvTv Therapeutics to Participate at the TD Cowen 44th Annual..
29/2/202401:26EDGAR2Form 8-K - Current report
29/2/202401:14EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202400:08EDGAR2Form 8-K - Current report
29/2/202400:00GLOBEvTv Therapeutics Announces $51 Million Private Placement..
23/2/202408:00PRNUSCANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO &..
23/12/202308:26EDGAR2Form 8-K - Current report
20/12/202308:28EDGAR2Form 8-K - Current report
13/12/202308:21EDGAR2Form 8-K - Current report
21/11/202308:23EDGAR2Form 8-K - Current report
16/11/202300:22EDGAR2Form 8-K - Current report
16/11/202300:19EDGAR2Form 8-K - Current report
10/11/202308:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202308:30GLOBEvTv Therapeutics Announces 2023 Third Quarter Financial..
10/11/202308:20EDGAR2Form 8-K - Current report
09/11/202300:00GLOBEvTv Therapeutics to Participate at the Stifel 2023..
02/11/202323:00GLOBEvTv Therapeutics Appoints Thomas Strack, M.D., as Chief..
01/11/202323:24EDGAR2Form 8-K - Current report
01/11/202323:00GLOBEvTv Therapeutics Announces Sale of Shares in Reneo..
27/9/202322:30PRNUSCANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A..
26/9/202322:30PRNUSCantex and Allegheny Health Network Announce Initiation of a..
26/9/202306:20EDGAR2Form DEF 14C - Other definitive information statements
18/9/202322:30PRNUSCANTEX PHARMACEUTICALS AND LENOX HILL HOSPITAL ANNOUNCE..
16/9/202306:17EDGAR2Form PRE 14C - Other preliminary information statements
12/8/202306:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202306:36EDGAR2Form 8-K - Current report
12/8/202306:30GLOBEvTv Therapeutics Announces 2023 Second Quarter Financial..
10/8/202322:33PRNUSCantex Pharmaceuticals Announces Article Published in npj..
21/7/202306:22EDGAR2Form 8-K - Current report
16/6/202322:00GLOBEvTv Therapeutics Partner Cantex Pharmaceuticals Licenses..
15/6/202321:33PRNUSCANTEX PHARMACEUTICALS TO PRESENT AT THE MEDINVEST ONCOLOGY..
24/5/202323:00GLOBEvTv Therapeutics Announces Issuance of U.S. Patent for..
12/5/202306:15GLOBEvTv Therapeutics Announces 2023 First Quarter Financial..

Your Recent History

Delayed Upgrade Clock